Qualcomm Stock: 5G Leader at a Bargain Price?
Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…
Sell
22
CVM Quote, Financials, Valuation and Earnings
Last price:
$0.30
Seasonality move
:
15.75%
Day range:
$0.30 - $0.32
52-week range:
$0.29 - $2.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.08x
Volume:
583.4K
Avg. volume:
1M
1-year change:
-85.59%
Market cap:
$23.5M
Revenue:
--
EPS (TTM):
-$0.48
Analysts' Opinion
-
Consensus RatingCEL-SCI has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $7.40, CEL-SCI has an estimated upside of 2334.21% from its current price of $0.30.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $0.30.
Fair Value
-
According to the consensus of 1 analyst, CEL-SCI has 2334.21% upside to fair value with a price target of $7.40 per share.
CVM vs. S&P 500
-
Over the past 5 trading days, CEL-SCI has underperformed the S&P 500 by -8.37% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
CEL-SCI does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CEL-SCI has grown year-over-year revenues for 1 quarter straight. In the most recent quarter CEL-SCI reported revenues of --.
Earnings Growth
-
CEL-SCI has grown year-over-year earnings for 0 quarters straight. In the most recent quarter CEL-SCI reported earnings per share of -$0.11.
Enterprise value:
18.9M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-1.04x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$34.9M | -$30.3M | -$26.8M | -$6.5M | -$6.9M | |
| EBITDA | -$30.9M | -$26.4M | -$22.6M | -$5.5M | -$5.9M | |
| Diluted EPS | -$0.85 | -$0.68 | -$0.48 | -$0.14 | -$0.11 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $23.7M | $41.9M | $20.4M | $6.2M | $5.9M | |
| Total Assets | $49.6M | $69.7M | $44.6M | $28.7M | $25.7M | |
| Current Liabilities | $7.3M | $3.3M | $4.7M | $4.9M | $5.5M | |
| Total Liabilities | $20.8M | $18.3M | $18M | $16.1M | $14.4M | |
| Total Equity | $28.8M | $51.4M | $26.6M | $12.7M | $11.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$18.1M | -$23.1M | -$18.1M | -$4.9M | -$4.1M | |
| Cash From Investing | -$674.4K | -$383.5K | -$76.2K | -$64.9K | -$33K | |
| Cash From Financing | -$316.5K | $8.7M | $19.5M | $4M | $4M | |
| Free Cash Flow | -$18.8M | -$23.5M | -$18.1M | -$5M | -$4.2M | |
CVM
Sector
Market Cap
$23.5M
$38.4M
Price % of 52-Week High
12.72%
45.53%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.78%
1-Year Price Total Return
-85.59%
-39.05%
Beta (5-Year)
0.666
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.32
200-day SMA
Sell
Level
$0.87
Bollinger Bands (100)
Sell
Level
0.37 - 0.75
Chaikin Money Flow
Sell
Level
-455.3M
20-day SMA
Sell
Level
$0.36
Relative Strength Index (RSI14)
Sell
Level
37.08
ADX Line
Buy
Level
13.21
Williams %R
Buy
Level
-85.0932
50-day SMA
Sell
Level
$0.39
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
251.4M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Stock Forecast FAQ
In the current month, CVM has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CVM average analyst price target in the past 3 months is $7.40.
-
Where Will CEL-SCI Stock Be In 1 Year?
According to analysts, the consensus estimate is that CEL-SCI share price will rise to $7.40 per share over the next 12 months.
-
What Do Analysts Say About CEL-SCI?
Analysts are divided on their view about CEL-SCI share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CEL-SCI is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is CEL-SCI's Price Target?
The price target for CEL-SCI over the next 1-year time period is forecast to be $7.40 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CVM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CEL-SCI is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of CVM?
You can purchase shares of CEL-SCI via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CEL-SCI shares.
-
What Is The CEL-SCI Share Price Today?
CEL-SCI was last trading at $0.30 per share. This represents the most recent stock quote for CEL-SCI. Yesterday, CEL-SCI closed at $0.30 per share.
-
How To Buy CEL-SCI Stock Online?
In order to purchase CEL-SCI stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is Buffett Buying and Selling Now?
In Q4 of last year, Warren Buffett made a few…
3 Safest Stocks to Buy Now
With the S&P 500 now in correction and stocks selling…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
59
GRRR alert for Mar 15
Gorilla Technology Group [GRRR] is up 29.72% over the past day.
Sell
49
SMTC alert for Mar 15
Semtech [SMTC] is up 21.28% over the past day.
Buy
62
PLPC alert for Mar 15
Preformed Line Products [PLPC] is up 17.38% over the past day.
